Cancer Family
Hepatobiliary Neoplasm
CI-CAN-00000198Explore in graph →
Non-malignant1,188 active trials17 approved drugs42 evidence items
- NCIt
- C8614
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000198Explore in graph →
Clinical trials
5,266 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04231929 | BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.(BIOPEARL-FIRST) | withdrawn | N/A | 0 | Terumo Europe N.V.INDUSTRY | 1 | Mar 28, 2022 | clinicaltrials |
| NCT04611100 | Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma | completed | N/A | 70 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV |
| 1 |
| Mar 23, 2022 |
| clinicaltrials |
| NCT01340105 | Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation | completed | N/A | 93 | Chinese University of Hong KongOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT01512407 | RCT on Adjuvant TACE After Hepatectomy for HCC(A-TECH) | completed | N/A | 58 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT01759901 | Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma | completed | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05281783 | RFA for Treatment of Intermediate Stage HCC | completed | N/A | 120 | Benha UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05277675 | Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)(RANT) | unknown | N/A | 160 | Southwest Hospital, ChinaOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03979547 | EXALT: EXercise Attenuates Liver Tumors Trial(EXALT) | terminated | N/A | 3 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05270642 | Plan for Microwave Thermal Field | unknown | N/A | 5 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04212286 | Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC | completed | N/A | 115 | Tianjin Third Central HospitalOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | unknown | N/A | 270 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT04847167 | Mechanistic Loop Resolution Strategy for Short-type Single Balloon Enteroscopy | completed | N/A | 23 | Ajou University School of MedicineOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT05247996 | TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma | unknown | N/A | 98 | The Central Hospital of Lishui CityOTHER | 0 | Feb 21, 2022 | clinicaltrials |
| NCT05242757 | Clinical Study of MAK Immune Cells in the Treatment of PHC | unknown | N/A | 12 | Zhongnan HospitalOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT04722120 | Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC | completed | N/A | 68 | Seoul National University HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02009176 | Laparoscope Anatomical and Aon-anatomical Hepatectomy | unknown | N/A | 110 | Shuguo Zheng, MDOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05118451 | A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | unknown | N/A | 420 | Zhujiang HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05233358 | HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure | unknown | N/A | 176 | The Central Hospital of Lishui CityOTHER | 0 | Feb 10, 2022 | clinicaltrials |
| NCT05160740 | Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer(ICGMFITinPLC) | unknown | N/A | 348 | Zhujiang HospitalOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05162898 | Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma. | unknown | N/A | 90 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 27, 2022 | clinicaltrials |
| NCT03109262 | Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors | completed | N/A | 42 | Stanford UniversityOTHER | 1 | Jan 10, 2022 | clinicaltrials |
| NCT05056116 | A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer | unknown | N/A | 30 | The Affiliated Hospital of Xuzhou Medical UniversityOTHER | 1 | Dec 27, 2021 | clinicaltrials |
| NCT05068076 | Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC | completed | N/A | 21 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT03731910 | Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE | unknown | N/A | 35 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT03796819 | Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma(LND for ICC) | completed | N/A | 260 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT04847726 | Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma | completed | N/A | 110 | Seoul National University HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT03113955 | STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma | completed | N/A | 109 | Varian Medical SystemsINDUSTRY | 1 | Dec 1, 2021 | clinicaltrials |
| NCT05121571 | The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study | completed | N/A | 114 | Sun Yat-sen UniversityOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT02232932 | Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma(TRANSPHIL) | unknown | N/A | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 3, 2021 | clinicaltrials |
| NCT03926039 | Sharing Decision-making Program for HCC Patients Treatment Decisions | completed | N/A | 70 | National Taipei University of Nursing and Health SciencesOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05017922 | Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma | completed | N/A | 89 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05032014 | Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer | unknown | N/A | 46 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT01141478 | Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria(HCC) | terminated | N/A | 8 | Loma Linda UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03644173 | Personal Resilience Empowerment Program Study | completed | N/A | 37 | Hackensack Meridian HealthOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT01387503 | Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | completed | N/A | 74 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01642446 | Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension | completed | N/A | 160 | Sun Yat-sen UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT03591705 | TACE-HAIC vs. HAIC for Potentially Resectable HCC | unknown | N/A | 240 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04531228 | TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial(Thalen) | unknown | N/A | 60 | Yunfei YuanOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT05053386 | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma | unknown | N/A | 186 | Zhejiang Cancer HospitalOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04891874 | Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI | completed | N/A | 76 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05038397 | A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial(Therasphere) | completed | N/A | 30 | MedicalExcellenceOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04455932 | HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation | recruiting | N/A | 476 | Concord Repatriation General HospitalOTHER | 2 | Sep 8, 2021 | clinicaltrials |
| NCT02329106 | Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02332551 | Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02333773 | Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli(IRE) | completed | N/A | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02352935 | Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function | completed | N/A | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02430662 | Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms(IRE) | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04301999 | Clinical Effect and Safety of PDT and RFA for Unresectable EHCC | completed | N/A | 67 | First People's Hospital of HangzhouOTHER | 1 | Sep 1, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Mar 28, 2022source: clinicaltrials